Updated: 27.08.2020
PRESTIGE-AF Study: 20 Participants
Predictive Modelling of Risk Substudy: 8 Participants
Pharmacology Substudy: 1 Participant
Longitudinal Neuroimaging Substudy: 1 Participant
Imperial College Healthcare NHS Trust – UK: 5 Participants
Hospital Dr Josep Trueta, Girona – Spain: 3 Participants
Northumbria Healthcare NHS Foundation Trust – UK: 2 Participants
Essen – Germany: 2 Participants
Hull and East Yorkshire NHS Trust – UK: 1 Participant
Mid Yorkshire Hospitals NHS Trust – UK: 1 Participant
Altenburg – Germany: 1 Participant
Tübingen – Germany: 1 Participant
Leipzig – Germany: 1 Participant
Johannes Wesling Clinic Minden – Germany: 1 Participant
Graz – Austria: 1 Participant
411 Germans Trias I Pujol Hospital Barcelona – Spain: 1 Participant
For more information about PRESTIGE-AF clinical trials and patient eligibility, contact us.
